Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer

Fig. 4

Preparation and Characterization of TGFβ-1 siRNA LNP. A Particle size of TGFβ-1 siRNA LNP. B Average zeta-potential of TGFβ-1 siRNA LNP in pH 6.0 and pH 7.4 buffers. C TEM images of TGFβ-1 siRNA LNP. D Sample of NC siRNA LNP and TGFβ-1 siRNA LNP. E IC50 of cabazitaxel API and CTX-HSA-NPs on A549/T cells. F Combined inhibitory effect of CTX-HSA-NPs combined with TGFβ-1 siRNA LNP on A549/T cells. G Cytotoxicity of cabazitaxel API and CTX-HSA-NPs on A549/T cells. H The paclitaxel RI of A549/T cells

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us